Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2018

View Archived Issues

Evotec and Petra Pharma to apply the INDiGO platform and accelerate Petra-01 development

First patient treated in phase Ib/II study of tractinostat in EBV+ lymphoma

FIMECS, Takeda enter license agreement to develop novel immuno-oncology therapies

Zealand, Roche Diabetes Care collaborate in phase III trial of dasiglucagon for CHI

United Neuroscience announces collaboration to evaluate vaccine candidates for Alzheimer's

miR-31 and miR-3150b predict EGFR TKI efficacy in squamous cell lung carcinoma

Veracyte enters collaboration with Loxo Oncology to advance oncology precision medicine

CNTO-3157 fails to attenuate rhinovirus-induced experimental asthma exacerbations

Treos Bio activates U.S. site in phase I trial of PolyPEPI-1018

Novel LDLR-PCSK9 protein-protein interaction inhibitors discovered at Texas A&M University

FDA lifts clinical hold on BPX-501 in U.S.

Assembly Biosciences presents new hepatitis B core protein modulators

Jiangsu Chia Tai Tianqing Pharmaceutical Group describes HBV capsid assembly inhibitors

Reata offers update on ongoing CARDINAL study of bardoxolone in Alport syndrome

Entasis Therapeutics patents new beta-lactamase inhibitors

CNRS, Universite d'Orleans identify novel agents for filovirus infections

Fujifilm Kyowa Kirin Biologics licenses rights to Mylan to commercialize adalimumab biosimilar

Destiny's discussions with FDA clarify overall clinical trial plans for XF-73

University of Oxford initiates phase I trial of MERS-CoV vaccine

Pfizer initiates comparative phase III study of aztreonam/avibactam in Gram-negative infections

Arbutus Biopharma and Roivant Sciences launch jointly owned Genevant Sciences

Mutation in FPN1 gene found to protect against malaria infection

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...